Specialities

Specialities

Respiratory Infections
Airway Diseases
Allergy
Asthma
Bronchiectasis
Bronchitis
Chronic Cough
COPD
COVID-19
Cystic Fibrosis
Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease
Interventional Pulmonology
Lung Cancer
Paediatric Respiratory Medicine
Respiratory Tract Disorders
Pulmonary Embolism
Pulmonary Hypertension
Respiratory Intensive Care
Rhinosinusitis
Sleep Related Breathing Disorders
Lung Transplantation and Surgery
Ventilation
Lung Health
Rare Disease Day
Emphysema
Rare Diseases
Search

Trending Topic
14 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

The Impact of Smart Inhalers on Personalized Asthma Management

Kate Clair Cruden Hughes, Amy Hai Yan Chan

Asthma affects nearly 300 million people worldwide.1 Despite a notable decline in age-standardized prevalence, mortality and disability-adjusted life years over the past three decades, the burden of asthma remains high in many countries including low-middle-income countries.2 Climate change is also predicted to significantly impact asthma and other respiratory-related conditions, as rising global temperatures lead to longer pollen […]

touchREVIEWS in Respiratory & Pulmonary Diseases. 2025;10(1):Online ahead of journal publication

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin

Search Results

Showing Results for camlipixant

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
Mark CompleteCompleted
BookmarkBookmarked

Greatest Hits of 2024

As 2024 draws to a close, we’re celebrating a fantastic year of content.
Mark CompleteCompleted
BookmarkBookmarked

Foreword - touchREVIEWS in Respiratory & Pulmonary Diseases, Volume 9, Issue 1, 2024

Welcome to the latest edition of touchREVIEWS in Respiratory & Pulmonary Diseases. As we continually strive to deliver cutting-edge research and insightful commentary, this issue is no exception, featuring a diverse array of articles that illuminate both emerging treatments and ...

touchREVIEWS in Respiratory & Pulmonary Diseases. 2024;9(1):1-2
Developed by Touch
Coverage from: ERS Highlights

P2X3 receptor antagonists for the treatment of chronic cough: Imran Satia, ERS 2023

View Coverage
Mark CompleteCompleted
BookmarkBookmarked

Camlipixant: A New Treatment Option for Refractory Chronic Cough?

Stephen K Field

Chronic cough is a cough that lasts 8 weeks or longer and is not due to serious underlying conditions. It is a common problem in primary care, accounting for up to 40% of referrals to pulmonologists.1 Common causes include rhinosinusitis, cough-variant asthma, ...

touchREVIEWS in Respiratory & Pulmonary Diseases. 2024;9(1):3-5

Latest articles videos and clinical updates - straight to your inbox

Close Popup